Treatments for cesarean scar pregnancy: 11-year experience at a medical center

被引:14
|
作者
Huo, Suxia [1 ]
Shen, Liang [2 ]
Ju, Ying [3 ]
Liu, Keke [4 ]
Liu, Wei [2 ,5 ]
机构
[1] Shandong Univ Tradit Chinese, Dept Obstet & Gynecol, Affiliated Hosp 2, Jinan, Peoples R China
[2] Shandong First Med Univ, Dept Obstet & Gynecol, Shandong Prov Hosp, Jinan, Peoples R China
[3] Shandong First Med Univ, Dept Clin Lab, Shandong Prov Hosp, Jinan, Peoples R China
[4] Shandong First Med Univ, Shandong Acad Clin Med, Shandong Prov Hosp, Jinan, Peoples R China
[5] Shandong First Med Univ, Dept Obstet & Gynecol, Shandong Prov Hosp, 324 Jingwu Rd, Jinan 250021, Shandong, Peoples R China
来源
关键词
Classification; dilation and curettage; hysteroscopy; laparoscopy; uterine artery embolization; UTERINE ARTERY EMBOLIZATION; ECTOPIC PREGNANCIES; LAPAROSCOPIC MANAGEMENT; DIAGNOSIS; CLASSIFICATION; CURETTAGE;
D O I
10.1080/14767058.2022.2162818
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background Cesarean scar pregnancy (CSP) is a long-term complication after cesarean section that can cause severe maternal morbidity and mortality. Although a variety of treatments have been described, there is no consensus as to the optimal management approach. Many grading systems for CSP have been proposed, among which the classification made by the consensus of Chinese experts in 2016 was shown to provide improved treatment guidance for clinical practice. The purpose of the present study was to analyze the success rate of different treatments for each type of CSP as classified according to the Chinese Expert's Consensus (2016), and to develop a management strategy for CSP. Methods A retrospective study was performed among patients diagnosed with CSP at Shandong Provincial Hospital between January 2009 and December 2019. We reviewed clinical characteristics, treatment methods, and subsequent outcomes; and analyzed these endpoints using the statistical software package SPSS 22.0 (SPSS, Inc., Chicago, IL). Results For type I CSP, systemic methotrexate (MTX) administration exhibited a success rate of 79.2% for type Ia and 14.3% for type Ib. Local and systemic MTX administration success rates were 88.9% for type Ia and 66.7% for type Ib. Dilation and curettage (D&C), curettage after uterine artery embolization (UAE + C), and hysteroscopic curettage (H + C) were 100% successful. For type II, UAE + C, H + C, and laparoscopy combined with hysteroscopic curettage (L + H+C) were 100% successful. D&C had a success rate of 97.0% for type IIa and 88.9% for type IIb. The success rate of systemic MTX administration was 52.0% for type IIa and 62.5% for type IIb. Both UAE + C and L + H+C had 100% success rates for type IIIa CSPs, while for type IIIb, the success rate was 87.9% for UAE + C vs. 96.6% for L + H+C. Conclusions For type I CSPs, D&C was quick, easy, and safe; for type II, H + C was more suitable. For type III and some type II patients who wished to undergo simultaneous repair of the cesarean defect, L + H+C was the optimal method. UAE can be used as a complementary option instead of a prophylactic measure, and when difficulties with endoscopic surgeries were encountered, conversion to laparotomy was the ultimate treatment.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] BhCG decline following intrasac methotrexate for the management of cesarean-scar ectopic pregnancy: An 11-year experience.
    Nguyen, Bianca
    Nasrallah, Sebastian
    Raza, Masooma
    Shah, Ankit
    McLeod, Francine
    Gomez, Luis M.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 230 (01) : S154 - S154
  • [2] Cesarean Scar Pregnancy: A Tertiary Care Center Experience
    Ghazali, Sarah M.
    INTERNATIONAL JOURNAL OF WOMENS HEALTH AND REPRODUCTION SCIENCES, 2023, 11 (04): : 191 - 196
  • [3] Experience in management of cesarean scar pregnancy and outcomes in a single center
    Wu, Dong-fang
    Zhang, Hong-xia
    He, Wen
    Liu, Xin
    Song, Hai-man
    Yu, Teng-fei
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (10)
  • [4] An 11-year experience with ovarian surgery during pregnancy
    Koo, Fan-Hlan
    Wang, Kuan-Chin
    Chen, Chih-Yao
    Chang, Wen-Hsun
    Yeh, Chang-Ching
    Yang, Ming-Jie
    Yen, Ming-Shyen
    Wang, Peng-Hui
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2013, 76 (08) : 452 - 457
  • [5] CESAREAN SECTION - AN 11-YEAR REVIEW
    POWELL, DV
    STEVENS, LA
    LEONARD, MWE
    OBSTETRICS AND GYNECOLOGY, 1958, 11 (01): : 19 - 29
  • [6] Medical Treatment of Cesarean Scar Pregnancy
    de Vaate, A. J. M. Bij
    Huirne, J. A. F.
    van der Slikke, J. H.
    Schats, R.
    Brolmann, H. A. M.
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2010, 17 (01) : 133 - 133
  • [7] Cesarean Scar Pregnancy, Incidence, and Recurrence Five-Year Experience at a Single Tertiary Care Referral Center
    Grechukhina, Olga
    Deshmukh, Uma
    Fan, Linda
    Kohari, Katherine
    Abdel-Razeq, Sonya
    Bahtiyar, Mert Ozan
    Sfakianaki, Anna K.
    OBSTETRICS AND GYNECOLOGY, 2018, 132 (05): : 1285 - 1295
  • [8] Systematic evaluation of the efficacy of treatments for cesarean scar pregnancy
    Sun, Haiying
    Wang, Juan
    Fu, Peiying
    Zhou, Ting
    Liu, Ronghua
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2024, 22 (01)
  • [9] Medical management of cesarean scar pregnancy implantation
    Greco, Patricia
    Bayer, Samantha
    Day, Lori
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S720 - S720
  • [10] Redo-MVR operations: a 11-year single center experience
    Bajraktari, A. Artan
    Bytyci, I.
    Prifti, E.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 573 - 573